BioNTech Raises USD 325 Million in an Upsized Series B Financing to Further Advance Individualized Immuno-Oncology Pipeline

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2XDlN2m
via IFTTT